<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1543" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1543/" /><meta name="ncbi_pagename" content="Focal Dermal Hypoplasia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Focal Dermal Hypoplasia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Focal Dermal Hypoplasia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/07/21" /><meta name="citation_author" content="Bret Bostwick" /><meta name="citation_author" content="Ignatia B Van den Veyver" /><meta name="citation_author" content="V Reid Sutton" /><meta name="citation_pmid" content="20301712" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1543/" /><meta name="citation_keywords" content="Goltz Syndrome" /><meta name="citation_keywords" content="Goltz-Gorlin Syndrome" /><meta name="citation_keywords" content="Goltz Syndrome" /><meta name="citation_keywords" content="Goltz-Gorlin Syndrome" /><meta name="citation_keywords" content="Protein-serine O-palmitoleoyltransferase porcupine" /><meta name="citation_keywords" content="PORCN" /><meta name="citation_keywords" content="Focal Dermal Hypoplasia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Focal Dermal Hypoplasia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Bret Bostwick" /><meta name="DC.Contributor" content="Ignatia B Van den Veyver" /><meta name="DC.Contributor" content="V Reid Sutton" /><meta name="DC.Date" content="2016/07/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1543/" /><meta name="description" content="Focal dermal hypoplasia is a multisystem disorder characterized primarily by involvement of the skin, skeletal system, eyes, and face. Skin manifestations present at birth include atrophic and hypoplastic areas of skin; cutis aplasia; fat nodules in the dermis manifesting as soft, yellow-pink cutaneous nodules; and pigmentary changes. Verrucoid papillomas of the skin and mucous membranes may appear later. The nails can be ridged, dysplastic, or hypoplastic; hair can be sparse or absent. Limb malformations include oligo-/syndactyly and split hand/foot. Developmental abnormalities of the eye can include anophthalmia/microphthalmia, iris and chorioretinal coloboma, and lacrimal duct abnormalities. Craniofacial findings can include facial asymmetry, notched alae nasi, cleft lip and palate, and pointed chin. Occasional findings include dental anomalies, abdominal wall defects, diaphragmatic hernia, and renal anomalies. Psychomotor development is usually normal; some individuals have cognitive impairment." /><meta name="og:title" content="Focal Dermal Hypoplasia" /><meta name="og:type" content="book" /><meta name="og:description" content="Focal dermal hypoplasia is a multisystem disorder characterized primarily by involvement of the skin, skeletal system, eyes, and face. Skin manifestations present at birth include atrophic and hypoplastic areas of skin; cutis aplasia; fat nodules in the dermis manifesting as soft, yellow-pink cutaneous nodules; and pigmentary changes. Verrucoid papillomas of the skin and mucous membranes may appear later. The nails can be ridged, dysplastic, or hypoplastic; hair can be sparse or absent. Limb malformations include oligo-/syndactyly and split hand/foot. Developmental abnormalities of the eye can include anophthalmia/microphthalmia, iris and chorioretinal coloboma, and lacrimal duct abnormalities. Craniofacial findings can include facial asymmetry, notched alae nasi, cleft lip and palate, and pointed chin. Occasional findings include dental anomalies, abdominal wall defects, diaphragmatic hernia, and renal anomalies. Psychomotor development is usually normal; some individuals have cognitive impairment." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1543/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/focal-dh/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1543/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C476BE0409F510000000004E901D4.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1543_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1543_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fhs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/issd/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1543_"><span class="title" itemprop="name">Focal Dermal Hypoplasia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Goltz Syndrome, Goltz-Gorlin Syndrome</div><p class="contrib-group"><span itemprop="author">Bret Bostwick</span>, MD, <span itemprop="author">Ignatia B Van den Veyver</span>, MD, and <span itemprop="author">V Reid Sutton</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1543_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1543_ai__"><div class="contrib half_rhythm"><span itemprop="author">Bret Bostwick</span>, MD<div class="affiliation small">Assistant Professor, Department of Molecular and Human Genetics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@kciwtsob" class="oemail">ude.mcb@kciwtsob</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ignatia B Van den Veyver</span>, MD<div class="affiliation small">Professor, Departments of Obstetrics and Gynecology and Molecular and Human Genetics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.cmt.mcb@revyevi" class="oemail">ude.cmt.mcb@revyevi</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">V Reid Sutton</span>, MD<div class="affiliation small">Professor, Department of Molecular and Human Genetics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.snerdlihcsaxet@nottusrv" class="oemail">gro.snerdlihcsaxet@nottusrv</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 15, 2008</span>; Last Update: <span itemprop="dateModified">July 21, 2016</span>.</p><p><em>Estimated reading time: 32 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="focal-dh.Summary" itemprop="description"><h2 id="_focal-dh_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Focal dermal hypoplasia is a multisystem disorder characterized primarily by involvement of the skin, skeletal system, eyes, and face. Skin manifestations present at birth include atrophic and hypoplastic areas of skin; cutis aplasia; fat nodules in the dermis manifesting as soft, yellow-pink cutaneous nodules; and pigmentary changes. Verrucoid papillomas of the skin and mucous membranes may appear later. The nails can be ridged, dysplastic, or hypoplastic; hair can be sparse or absent. Limb malformations include oligo-/syndactyly and split hand/foot. Developmental abnormalities of the eye can include anophthalmia/microphthalmia, iris and chorioretinal coloboma, and lacrimal duct abnormalities. Craniofacial findings can include facial asymmetry, notched alae nasi, cleft lip and palate, and pointed chin. Occasional findings include dental anomalies, abdominal wall defects, diaphragmatic hernia, and renal anomalies. Psychomotor development is usually normal; some individuals have cognitive impairment.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Focal dermal hypoplasia can be diagnosed based on clinical findings in individuals with classic ectodermal findings and characteristic limb malformations. Molecular genetic testing may be useful to confirm the diagnosis in these individuals and is used to establish the diagnosis in individuals in whom the clinical findings are inconclusive.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Care by a dermatologist for painful and pruritic erosive lesions that are prone to infection; referral to an otolaryngologist or gastroenterologist for evaluation and management of large papillomas of the larynx and/or trachea or esophagus causing gastroesophageal disease (GERD); referral to a physical/occupational therapist and hand surgeon for management of hand and foot malformations; standard protocols for management of structural abnormalities of the eyes and kidneys and diaphragmatic hernia and abdominal wall defects.</p><p><i>Prevention of secondary complications:</i> Preoperative evaluation by an otolaryngologist for hypopharyngeal and/or tonsillar papillomas.</p><p><i>Surveillance:</i> Routine follow up with a dermatologist; routine evaluations for scoliosis, particularly in individuals with costovertebral segmentation abnormalities; routine monitoring of growth and body composition to determine need for nutritional intervention; regular eye examinations; routine screening for cognitive, emotional, behavioral, and adaptive issues.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Focal dermal hypoplasia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. Females (90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> or mosaic for a <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; live-born affected males (10% of affected individuals) are mosaic for a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>PORCN</i> pathogenic variant. It is presumed that non-mosaic <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> males are not viable. Approximately 95% of females with focal dermal hypoplasia have a <i>de novo</i> pathogenic variant; ~5% inherited the pathogenic variant from a parent. The risk that the <i>PORCN</i> pathogenic variant will be transmitted by an affected heterozygous female is 50%; however, because most male conceptuses with a <i>PORCN</i> pathogenic variant are presumed to be spontaneously aborted, at delivery the expected sex ratio of offspring is: 33% unaffected females; 33% affected females; 33% unaffected males. If the affected female is mosaic for a <i>PORCN</i> pathogenic variant, the risk to her female offspring of inheriting the pathogenic variant depends on the level of <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> in her <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> and can be as high as 50%. Prenatal diagnosis for pregnancies at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the pathogenic variant in the family has been identified.</p></div></div><div id="focal-dh.Diagnosis"><h2 id="_focal-dh_Diagnosis_">Diagnosis</h2><div id="focal-dh.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Focal dermal hypoplasia, a multisystem disorder primarily involving the skin, skeletal system, eyes, and face, <b>should be considered</b> in an individual with following clinical findings.</p><div id="focal-dh.Major_Findings"><h4>Major Findings</h4><p>Characteristic <b>ectodermal</b>
<b>manifestations</b> include the following (see <a class="figpopup" href="/books/NBK1543/figure/focal-dh.F1/?report=objectonly" target="object" rid-figpopup="figfocaldhF1" rid-ob="figobfocaldhF1">Figure 1</a>):</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figfocaldhF1" co-legend-rid="figlgndfocaldhF1"><a href="/books/NBK1543/figure/focal-dh.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figfocaldhF1" rid-ob="figobfocaldhF1"><img class="small-thumb" src="/books/NBK1543/bin/focal-dh-Image001.gif" src-large="/books/NBK1543/bin/focal-dh-Image001.jpg" alt="Figure 1. . Ectodermal manifestations include yellowish-pink areas representing fat herniation (white arrowheads), patchy aplasia (black arrowheads), hyper-/hypopigmentation following lines of Blaschko (black arrows indicating the border), and hypopigmented areas of poikiloderma (circled regions)." /></a><div class="icnblk_cntnt" id="figlgndfocaldhF1"><h4 id="focal-dh.F1"><a href="/books/NBK1543/figure/focal-dh.F1/?report=objectonly" target="object" rid-ob="figobfocaldhF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Ectodermal manifestations include yellowish-pink areas representing fat herniation (white arrowheads), patchy aplasia (black arrowheads), hyper-/hypopigmentation following lines of Blaschko (black arrows indicating the border), and hypopigmented areas <a href="/books/NBK1543/figure/focal-dh.F1/?report=objectonly" target="object" rid-ob="figobfocaldhF1">(more...)</a></p></div></div><ul><li class="half_rhythm"><div class="half_rhythm"><b>Congenital patchy skin aplasia</b> (95% of individuals) evidenced by atrophic and hypoplastic areas of skin that often follow the lines of Blaschko and appear as depressed regions of pink or white color, often with a fibrous texture.</div><div class="half_rhythm">Note: The lines of Blaschko correspond to cell migration pathways evident during embryonic and fetal skin development. Like dermatomes, the lines of Blaschko are linear on the limbs and circumferential on the trunk. Unlike dermatomes, the lines of Blaschko do not correspond to innervation patterns.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Congenital skin hypo- or hyperpigmentation</b> (90%-100%) often following a Blaschko linear distribution</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Congenital nodular fat herniation</b> (60%-70%), evidenced by soft, yellow-pink nodules on the skin (which represent fat nodules in the dermis) that are typically seen on the trunk and extremities</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Congenital ridged, dysplastic, or hypoplastic nails</b> (80%-90%)</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Telangiectasias</b> (~80%) (may be seen on the face, trunk, and extremities)</div></li></ul><p>Characteristic <b>limb malformations</b> [<a class="bk_pop" href="#focal-dh.REF.smith.2016.41">Smith &#x00026; Hunt 2016</a>] include the following (see <a class="figpopup" href="/books/NBK1543/figure/focal-dh.F2/?report=objectonly" target="object" rid-figpopup="figfocaldhF2" rid-ob="figobfocaldhF2">Figure 2</a> and <a class="figpopup" href="/books/NBK1543/figure/focal-dh.F3/?report=objectonly" target="object" rid-figpopup="figfocaldhF3" rid-ob="figobfocaldhF3">Figure 3</a>):</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figfocaldhF2" co-legend-rid="figlgndfocaldhF2"><a href="/books/NBK1543/figure/focal-dh.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figfocaldhF2" rid-ob="figobfocaldhF2"><img class="small-thumb" src="/books/NBK1543/bin/focal-dh-Image002.gif" src-large="/books/NBK1543/bin/focal-dh-Image002.jpg" alt="Figure 2. . Hands showing syndactyly (black arrow) and split-hand malformation (black arrowhead) with only four digits (oligodactyly) on the left hand." /></a><div class="icnblk_cntnt" id="figlgndfocaldhF2"><h4 id="focal-dh.F2"><a href="/books/NBK1543/figure/focal-dh.F2/?report=objectonly" target="object" rid-ob="figobfocaldhF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Hands showing syndactyly (black arrow) and split-hand malformation (black arrowhead) with only four digits (oligodactyly) on the left hand. The appearance of the left hand has been somewhat modified by partial surgical repair. </p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figfocaldhF3" co-legend-rid="figlgndfocaldhF3"><a href="/books/NBK1543/figure/focal-dh.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figfocaldhF3" rid-ob="figobfocaldhF3"><img class="small-thumb" src="/books/NBK1543/bin/focal-dh-Image003.gif" src-large="/books/NBK1543/bin/focal-dh-Image003.jpg" alt="Figure 3. " /></a><div class="icnblk_cntnt" id="figlgndfocaldhF3"><h4 id="focal-dh.F3"><a href="/books/NBK1543/figure/focal-dh.F3/?report=objectonly" target="object" rid-ob="figobfocaldhF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">Highly variable limb malformations Feet showing syndactyly (black arrow), split-hand malformation or ectrodactyly (black arrowhead), oligodactyly (3, 6, 7, 8, 10, 11, 12), and distal transverse limb defect (13)</p></div></div><ul><li class="half_rhythm"><div><b>Syndactyly</b> (70%-90% of individuals) joining or webbing of &#x02265;2 fingers or toes, occurring variably on one or more extremities</div></li><li class="half_rhythm"><div><b>Ectrodactyly</b> (75%), a split hand/foot malformation that may occur on one or more extremities</div></li><li class="half_rhythm"><div><b>Oligodactyly</b> (20%-40%) &#x02013; &#x0003c;5 digits on a hand or foot, which may be seen in one or both hands or feet. Central digits are more frequently involved.</div></li><li class="half_rhythm"><div><b>Transverse limb defect</b> (15%) &#x02013; <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> absence of the hand, wrist, forearm, or elbow with no distal remaining portions, including acheiria or hemimelia</div></li><li class="half_rhythm"><div><b>Long bone reduction defect</b> (50%-80%) &#x02013; hypoplasia or shortening of the long bones in one or more extremities</div></li></ul></div><div id="focal-dh.Minor_Findings"><h4>Minor Findings</h4><p>Additional common features not included in the diagnostic criteria but supportive of the diagnosis include the following.</p><p><b>Ectodermal manifestations</b> [<a class="bk_pop" href="#focal-dh.REF.bree.2016.44">Bree et al 2016</a>, <a class="bk_pop" href="#focal-dh.REF.wright.2016.52">Wright et al 2016</a>]</p><ul><li class="half_rhythm"><div>Patchy alopecia of the scalp (80% of individuals) or wiry hair (65%)</div></li><li class="half_rhythm"><div>Verrucoid papillomas (65%) of the skin and mucous membranes (including in the mouth, nose, larynx, esophagus, vaginal mucosa, and/or rectal mucosa)</div></li><li class="half_rhythm"><div>Dental abnormalities including enamel defects / longitudinal grooving (65%), peg teeth (50%), or hypodontia (80%)</div></li><li class="half_rhythm"><div>Photosensitivity (40%)</div></li><li class="half_rhythm"><div>Pebbled skin texture (58%)</div></li><li class="half_rhythm"><div>Hair shaft abnormalities on scanning electron microscopy (80%-90%)</div></li></ul><p><b>Ocular manifestations</b> [<a class="bk_pop" href="#focal-dh.REF.gisseman.2016.59">Gisseman &#x00026; Herce 2016</a>]</p><ul><li class="half_rhythm"><div>Iris colobomas (50% of individuals)</div></li><li class="half_rhythm"><div>Chorioretinal colobomas (60%)</div></li><li class="half_rhythm"><div>Microphthalmia (45%) or anophthalmos (5%-10%)</div></li><li class="half_rhythm"><div>Cataracts (10%)</div></li><li class="half_rhythm"><div>Nystagmus (30%) or strabismus (20%)</div></li></ul></div></div><div id="focal-dh.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>Focal dermal hypoplasia can be diagnosed based on clinical findings in individuals with classic ectodermal findings and characteristic limb malformations. Molecular genetic testing may be useful to confirm the diagnosis in these individuals and is used to establish the diagnosis in individuals in whom the clinical findings are inconclusive.</p><p>The diagnosis of focal dermal hypoplasia <b>is established</b> in a female or male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the following clinical and/or molecular genetic findings.</p><div id="focal-dh.Clinical_Findings"><h4>Clinical Findings</h4><p>Focal dermal hypoplasia can be diagnosed clinically in individuals with three or more characteristic <a href="#focal-dh.Major_Findings">major</a> ectodermal manifestations AND at least one characteristic <a href="#focal-dh.Major_Findings">major</a> limb malformation [<a class="bk_pop" href="#focal-dh.REF.bostwick.2016.9">Bostwick et al 2016</a>].</p><p>Note: (1) Skin manifestations should be <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> in onset to distinguish from a similar skin <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> seen in <a href="/books/n/gene/rts/">Rothmund-Thomson syndrome</a>. (2) <a href="#focal-dh.Minor_Findings">Minor</a> findings alone are not sufficient to establish a clinical diagnosis, but when present should increase suspicion for focal dermal hypoplasia.</p></div><div id="focal-dh.Molecular_Genetic_Findings"><h4>Molecular Genetic Findings</h4><p>Identification of a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in a female or somatic mosaic <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <i>PORCN</i> pathogenic variant or deletion in a male (see <a class="figpopup" href="/books/NBK1543/table/focal-dh.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figfocaldhTmoleculargenetictestinguse" rid-ob="figobfocaldhTmoleculargenetictestinguse">Table 1</a>) confirms the diagnosis in individuals with characteristic clinical findings and establishes the diagnosis when clinical findings are ambiguous or inconclusive.</p><p>Note: Nearly all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males to date have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#focal-dh.REF.grzeschik.2007.833">Grzeschik et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.wang.2007.836">Wang et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.lombardi.2011.723">Lombardi et al 2011</a>]; the one notable exception is two brothers who were hemizygous for an inherited novel <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant that was likely a <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#focal-dh.REF.brady.2015.551">Brady et al 2015</a>].</p><p>Tiered molecular testing approaches can include a combination of <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>), <b><a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA)</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p><b>First-tier testing.</b> On a blood sample, perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>PORCN</i>. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified, perform either CMA (if not already performed) to detect large deletions/duplications that include <i>PORCN</i> or <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>PORCN</i> if CMA was normal; note, however, that intragenic deletions detected by this method have been reported rarely (see <a class="figpopup" href="/books/NBK1543/table/focal-dh.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figfocaldhTmoleculargenetictestinguse" rid-ob="figobfocaldhTmoleculargenetictestinguse">Table 1</a>).</p><p>Note: (1) Several females and nearly all males have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for either a <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>; therefore, possible mosaicism must be considered when performing <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> (see <b>Second-tier testing</b>). (2) A male with a 47,XXY <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>PORCN</i> pathogenic variant on one of the two X chromosomes has been reported [<a class="bk_pop" href="#focal-dh.REF.alkindi.2013.476">Alkindi et al 2013</a>].</p><p><b>Second-tier testing.</b> If first-tier testing does not detect a <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> on saliva or <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> tissues (e.g., skin, papillomas, surgical specimens), which increase the <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> for detecting <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> [<a class="bk_pop" href="#focal-dh.REF.maas.2009.716">Maas et al 2009</a>].</p><p><b>Testing to consider.</b> If first-tier and second-tier testing do not detect a <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, the following may also be considered:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>PORCN</i> and other genes of interest (see <a href="#focal-dh.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="focal-dh.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Focal Dermal Hypoplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1543/table/focal-dh.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__focal-dh.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_focal-dh.T.molecular_genetic_testing_use_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_focal-dh.T.molecular_genetic_testing_use_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_focal-dh.T.molecular_genetic_testing_use_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method&#x000a0;<sup>3,&#x000a0;4</sup></th></tr></thead><tbody><tr><td headers="hd_h_focal-dh.T.molecular_genetic_testing_use_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PORCN</i></td><td headers="hd_h_focal-dh.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5,&#x000a0;6</sup></td><td headers="hd_h_focal-dh.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~91%&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_focal-dh.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>3</sup> (<a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> approach)</td><td headers="hd_h_focal-dh.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~9%&#x000a0;<sup>7,&#x000a0;8</sup></td></tr><tr><td headers="hd_h_focal-dh.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>9</sup></td><td headers="hd_h_focal-dh.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>7,&#x000a0;8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="focal-dh.TF.1.1"><p class="no_margin">See <a href="/books/NBK1543/#focal-dh.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="focal-dh.TF.1.2"><p class="no_margin">See <a href="#focal-dh.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="focal-dh.TF.1.3"><p class="no_margin">Estimates based on 170 individual positive test results curated in the <a href="https://databases.lovd.nl/shared/genes/PORCN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>PORCN @ LOVD </u></a>database [<a class="bk_pop" href="#focal-dh.REF.lombardi.2011.723">Lombardi et al 2011</a>]</p></div></dd><dt>4. </dt><dd><div id="focal-dh.TF.1.4"><p class="no_margin">Approximately 91% of pathogenic variants are detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>; ~9% of pathogenic variants are large deletions. Males with mosaic pathogenic variants represent ~10% of all described cases with pathogenic variants in <a href="https://databases.lovd.nl/shared/genes/PORCN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PORCN @ LOVD</a> [<a class="bk_pop" href="#focal-dh.REF.bornholdt.2009.e618">Bornholdt et al 2009</a>, <a class="bk_pop" href="#focal-dh.REF.froyen.2009.535">Froyen et al 2009</a>, <a class="bk_pop" href="#focal-dh.REF.fernandes.2010.709">Fernandes et al 2010</a>, <a class="bk_pop" href="#focal-dh.REF.lombardi.2011.723">Lombardi et al 2011</a>].</p></div></dd><dt>5. </dt><dd><div id="focal-dh.TF.1.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>6. </dt><dd><div id="focal-dh.TF.1.6"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>7. </dt><dd><div id="focal-dh.TF.1.7"><p class="no_margin">Nearly all 46,XY males and some females are mosaic for pathogenic variants in <i>PORCN</i>. When using <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may result in a false negative test result [<a class="bk_pop" href="#focal-dh.REF.grzeschik.2007.833">Grzeschik et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.wang.2007.836">Wang et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.bornholdt.2009.e618">Bornholdt et al 2009</a>, <a class="bk_pop" href="#focal-dh.REF.maas.2009.716">Maas et al 2009</a>, <a class="bk_pop" href="#focal-dh.REF.fernandes.2010.709">Fernandes et al 2010</a>, <a class="bk_pop" href="#focal-dh.REF.vreeburg.2011.592">Vreeburg et al 2011</a>, <a class="bk_pop" href="#focal-dh.REF.yoshihashi.2011.550">Yoshihashi et al 2011</a>].</p></div></dd><dt>8. </dt><dd><div id="focal-dh.TF.1.8"><p class="no_margin">Reported deletions have ranged from an intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> (exons 1-4) [<a class="bk_pop" href="#focal-dh.REF.bornholdt.2009.e618">Bornholdt et al 2009</a>] to large <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> deletions including <i>PORCN</i> and neighboring genes of up to 0.5 Mb [<a class="bk_pop" href="#focal-dh.REF.wang.2007.836">Wang et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.lombardi.2011.723">Lombardi et al 2011</a>].</p></div></dd><dt>9. </dt><dd><div id="focal-dh.TF.1.9"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications. Note that although gene-targeted deletion/duplication assays may detect smaller events than <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> deletion/duplication assays, they may not determine the size of a larger event.</p></div></dd></dl></div></div></div></div></div></div><div id="focal-dh.Clinical_Characteristics"><h2 id="_focal-dh_Clinical_Characteristics_">Clinical Characteristics</h2><div id="focal-dh.Clinical_Description"><h3>Clinical Description</h3><p>Focal dermal hypoplasia is a highly variable multisystem disorder caused by developmental abnormalities in mesodermal and ectodermal structures primarily involving the skin, limbs, eyes, and face. The manifestations vary among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and many have only a subset of the characteristic features.</p><p>Females account for 90% of individuals with focal dermal hypoplasia.</p><p>The phenotypes in both males and females are highly variable due to tissue <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a>: females have random <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> (functional mosaicism) while males nearly always have postzygotic <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>.</p><div id="focal-dh.Affected_Females"><h4>Affected Females</h4><p><b>Ectodermal manifestations.</b> The most characteristic features of focal dermal hypoplasia are the skin manifestations (<a class="figpopup" href="/books/NBK1543/figure/focal-dh.F1/?report=objectonly" target="object" rid-figpopup="figfocaldhF1" rid-ob="figobfocaldhF1">Figure 1</a>). The cutaneous findings typically follow the lines of Blaschko and include patchy areas of skin aplasia/hypoplasia, skin hypo- and/or hyper-pigmentation, and nodular fat herniation. The lines of Blaschko represent cell migration pathways that are linear on the limbs and circumferential on the trunk. The lines are classically described as V-shaped overlying the upper spine, S-shaped on the abdomen, and an inverted-U shape from the breast area to the upper arms. These findings are typically evident at birth, but the distribution and severity may change over time. Unilateral involvement has also been reported [<a class="bk_pop" href="#focal-dh.REF.tenkir.2010.28">Tenkir &#x00026; Teshome 2010</a>, <a class="bk_pop" href="#focal-dh.REF.maalouf.2012.85">Maalouf et al 2012</a>, <a class="bk_pop" href="#focal-dh.REF.asano.2013.120">Asano et al 2013</a>].</p><p>Other integumentary system abnormalities include wiry hair, sparse hair, patchy alopecia of the scalp, and abnormal nails. The nails can be absent (anonychia), small (micronychia), hypoplastic, or dysplastic, often with longitudinal ridging, splitting, or V-nicking [<a class="bk_pop" href="#focal-dh.REF.bree.2016.44">Bree et al 2016</a>].</p><p><b>Papillomatosis.</b> Papillomas and telangectasias are typically not present at birth but develop with age.</p><ul><li class="half_rhythm"><div>Verrucoid papillomas are found in the oral mucosa of the mouth, nose, pharynx, larynx, trachea, and esophagus. Large papillomas of the larynx can obstruct breathing during anesthesia or can cause obstructive sleep apnea. Papillomas in the esophagus or larynx can also cause or contribute to severe GERD.</div></li><li class="half_rhythm"><div>The vaginal or rectal mucosa are also common sites for papillomas, where they can be confused with genital warts.</div></li></ul><p>Dental abnormalities and eye findings, both of which result from abnormalities in ectodermal appendage development, are described separately below.</p><p><b>Limb and skeletal manifestations.</b> Most individuals with focal dermal hypoplasia have limb malformations noted at birth, including syndactyly, oligodactyly, and split-hand/foot malformation or ectrodactyly (<a class="figpopup" href="/books/NBK1543/figure/focal-dh.F2/?report=objectonly" target="object" rid-figpopup="figfocaldhF2" rid-ob="figobfocaldhF2">Figure 2</a> and <a class="figpopup" href="/books/NBK1543/figure/focal-dh.F3/?report=objectonly" target="object" rid-figpopup="figfocaldhF3" rid-ob="figobfocaldhF3">Figure 3</a>) [<a class="bk_pop" href="#focal-dh.REF.gorlin.1963.421">Gorlin et al 1963</a>, <a class="bk_pop" href="#focal-dh.REF.goltz.1970.1">Goltz et al 1970</a>]. These malformations, which do not change over time, may impair function.</p><p>Additionally, reduction defects of the long bones ranging from leg length discrepancies to transverse defects of the distal radius/ulna or tibia/fibula are commonly seen.</p><p>Less common limb malformations that may be present at birth and impair function include camptodactyly (contraction deformities of the digits) and brachydactyly (shortening of the digits).</p><p>Costovertebral segmentation abnormalities including fused ribs, bifid ribs, and hemivertebrae and butterfly vertebrae are present at birth but are often not evident on physical examination and may only be seen on x-ray of the chest and/or spine. Although these malformations do not typically cause problems in infancy or early childhood, they may cause scoliosis as the child grows. Kyphosis or kyphoscoliosis is seen in approximately 10% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#focal-dh.REF.smith.2016.41">Smith &#x00026; Hunt 2016</a>]. More often, these segmentation abnormalities do not cause health issues.</p><p>Diastasis pubis, an abnormal separation of the symphysis pubis, may be an incidental finding or may present in adolescence or adulthood with pain. The gap between the pubic bones in the average non-pregnant adult is 4-5 mm. An abnormal gap is considered to be 1 cm or more, sometimes with the two bones being slightly out of alignment. In some individuals with focal dermal hypoplasia, diastasis pubis may cause pain with walking or in the symphysis pubis, legs, groin, and lower abdomen.</p><p>Fibrous dysplasia of bone (i.e., replacement of medullary bone with trabeculae of woven bone containing fluid-filled cysts embedded in a fibrous matrix) may affect any bone at any time. On x-ray the bone appears radiolucent, with what is classically described as a "ground-glass" appearance. Fibrous dysplasia may be asymptomatic or become evident when it is the site of a pathologic fracture.</p><p>Giant cell-like tumors of long bones, reported on occasion, may develop in childhood, adolescence, or adulthood. They typically become evident when a pathologic bone fracture occurs at the site of the lesion [<a class="bk_pop" href="#focal-dh.REF.selzer.1974.714">Selzer et al 1974</a>, <a class="bk_pop" href="#focal-dh.REF.joannides.1983.684">Joannides et al 1983</a>, <a class="bk_pop" href="#focal-dh.REF.tanaka.1990.179">Tanaka et al 1990</a>]. In the small number of reports to date, none of these tumors has been malignant.</p><p>Osteopathia striata, a striated appearance of the bones evident on plain x-rays, is common and may be seen in childhood, adolescence, and adulthood. It is currently unclear if individuals with this finding are at increased risk for general osteoporosis. Of note, a spontaneous patella fracture related to osteoporosis in a patient with FDH has been reported [<a class="bk_pop" href="#focal-dh.REF.altschuler.2012.500">Altschuler et al 2012</a>].</p><p><b>Eye findings.</b> Developmental abnormalities of the eyes are common and are evident at birth. Depending on the severity of the manifestations, vision can range from 20/20 to no light perception. Reported eye abnormalities include anophthalmia/microphthalmia; microcornea; iris, chorioretinal and eyelid colobomas; lacrimal duct abnormalities; and cataracts (cortical and subcapsular) [<a class="bk_pop" href="#focal-dh.REF.gorlin.1963.421">Gorlin et al 1963</a>, <a class="bk_pop" href="#focal-dh.REF.goltz.1970.1">Goltz et al 1970</a>].</p><p>Strabismus and/or nystagmus can be observed when visual impairment in infancy is significant.</p><p><b>Craniofacial findings.</b> Facial features are variable and include facial asymmetry, notched alae nasi, pointed chin, and small underfolded pinnae. These facial characteristics are not typically evident at birth but develop with time (<a class="figpopup" href="/books/NBK1543/figure/focal-dh.F4/?report=objectonly" target="object" rid-figpopup="figfocaldhF4" rid-ob="figobfocaldhF4">Figure 4</a>) [<a class="bk_pop" href="#focal-dh.REF.gorlin.1963.421">Gorlin et al 1963</a>, <a class="bk_pop" href="#focal-dh.REF.goltz.1970.1">Goltz et al 1970</a>].</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figfocaldhF4" co-legend-rid="figlgndfocaldhF4"><a href="/books/NBK1543/figure/focal-dh.F4/?report=objectonly" target="object" title="Figure 4. " class="img_link icnblk_img figpopup" rid-figpopup="figfocaldhF4" rid-ob="figobfocaldhF4"><img class="small-thumb" src="/books/NBK1543/bin/focal-dh-Image004.gif" src-large="/books/NBK1543/bin/focal-dh-Image004.jpg" alt="Figure 4. . Note facial features of pointed chin and small right ear." /></a><div class="icnblk_cntnt" id="figlgndfocaldhF4"><h4 id="focal-dh.F4"><a href="/books/NBK1543/figure/focal-dh.F4/?report=objectonly" target="object" rid-ob="figobfocaldhF4">Figure 4. </a></h4><p class="float-caption no_bottom_margin">Note facial features of pointed chin and small right ear. </p></div></div><p>Cleft lip and palate can be present and may lead to difficulty with feeding. More severe facial clefting can cause feeding, breathing, and vision problems, as well as significant cosmetic concerns [<a class="bk_pop" href="#focal-dh.REF.ascherman.2002.469">Ascherman et al 2002</a>].</p><p><b>Oral and dental findings.</b> Oral manifestations are seen in more than half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and include both soft tissue and hard tissue abnormalities.</p><p>Enamel hypoplasia that predisposes to dental caries is the most common problem. Other findings include: hypodontia, oligodontia, supernumerary teeth, and dental crowding leading to malocclusion of both primary and secondary dentition; vertical grooving of the teeth; microdontia (small teeth); taurodontia (prism-shaped molars); fused teeth; and abnormal root morphology [<a class="bk_pop" href="#focal-dh.REF.balmer.2004.686">Balmer et al 2004</a>, <a class="bk_pop" href="#focal-dh.REF.tejani.2005.67">Tejani et al 2005</a>, <a class="bk_pop" href="#focal-dh.REF.murakami.2011.e11">Murakami et al 2011</a>]. Affected individuals may also have problems with the eruption and position of teeth. Natal teeth were described in one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual [<a class="bk_pop" href="#focal-dh.REF.dias.2010.305">Dias et al 2010</a>].</p><p>Soft tissue abnormalities include generalized gingivitis and intra-oral lipomas and papillomas.</p><p><b>Gastrointestinal and nutrition.</b> Problems include poor weight gain (77% of individuals), short stature (65%), oral motor dysfunction (41%), gastroesophageal reflux (24%), gastroparesis (35%), and constipation (35%) [<a class="bk_pop" href="#focal-dh.REF.motil.2016.29">Motil et al 2016</a>]. Food allergies &#x02013; primarily to milk, soy, and shellfish &#x02013; are present in 12% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p>Other developmental abnormalities of the digestive system are rare but may have severe consequences; they include abdominal wall defects and diaphragmatic hernia (see <a href="/books/n/gene/cdh-ov/">Congenital Diaphragmatic Hernia Overview</a>).</p><p>Severe gastroesophageal reflux disease (GERD) has been reported in infancy and childhood, leading to feeding difficulties with frequent vomiting and/or discomfort/distress. GERD likely results from esophageal papillomas [<a class="bk_pop" href="#focal-dh.REF.brinson.1987.1177">Brinson et al 1987</a>].</p><p><b>Renal and urogenital.</b> Genital labial hypoplasia is present in most females [<a class="bk_pop" href="#focal-dh.REF.adeyemifowode.2016.64">Adeyemi-Fowode et al 2016</a>]. Occasional <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with m&#x000fc;llerian anomalies, including bicornuate uterus, have been described [<a class="bk_pop" href="#focal-dh.REF.reddy.2009.e71">Reddy &#x00026; Laufer 2009</a>, <a class="bk_pop" href="#focal-dh.REF.lopezporras.2011.158">Lopez-Porras et al 2011</a>].</p><p>Renal structural abnormalities are uncommon, but previous case reports include unilateral absent kidney, hypoplastic kidney, fused/horseshoe kidney, or cystic renal dysplasia. If present, these abnormalities may lead to recurrent urinary tract infections and urinary reflux [<a class="bk_pop" href="#focal-dh.REF.suskan.1990.283">Suskan et al 1990</a>].</p><p><b>Cognitive and psychological.</b> Development and intellectual ability is normal in most individuals. Intellectual impairment (15%-20% of individuals), behavioral problems (~20%), emotional lability (40%-50%), and withdrawn behavior (65%) have been reported [<a class="bk_pop" href="#focal-dh.REF.deidrick.2016.34">Deidrick et al 2016</a>]. In those with emotional, behavioral, adaptive, and intellectual impairment, the spectrum of severity varies widely.</p><p>Structural brain abnormalities and spina bifida [<a class="bk_pop" href="#focal-dh.REF.goltz.1970.1">Goltz et al 1970</a>, <a class="bk_pop" href="#focal-dh.REF.almeida.1988.917">Almeida et al 1988</a>] have been reported but are uncommon.</p><p>Epilepsy has been reported [<a class="bk_pop" href="#focal-dh.REF.kanemura.2011.135">Kanemura et al 2011</a>].</p><p><b>Other.</b> Mixed conductive and sensorineural hearing loss has been reported on occasion.</p><p>When the first <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> female in the family has milder manifestations than affected females in subsequent generations [<a class="bk_pop" href="#focal-dh.REF.wechsler.1988.297">Wechsler et al 1988</a>, <a class="bk_pop" href="#focal-dh.REF.kilmer.1993.839">Kilmer et al 1993</a>], it is most likely that she has either <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for the <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or skewing of <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>. Alternative explanations could be reduced reproductive fitness in severely affected females, such that only mildly affected females reproduce.</p></div><div id="focal-dh.Affected_Males"><h4>Affected Males</h4><p>Because relatively few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males have been reported, no comprehensive data for a "typical" male <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> exist.</p><p>Affected males may have any of the features seen in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females including typical skin findings; sparse, brittle hair; nail dystrophy; microphthalmia; syndactyly; split-hand/foot malformation; costovertebral segmentation abnormalities; osteopathia striata; and diastasis pubis [<a class="bk_pop" href="#focal-dh.REF.wang.2007.836">Wang et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.bornholdt.2009.e618">Bornholdt et al 2009</a>, <a class="bk_pop" href="#focal-dh.REF.maas.2009.716">Maas et al 2009</a>, <a class="bk_pop" href="#focal-dh.REF.lombardi.2011.723">Lombardi et al 2011</a>, <a class="bk_pop" href="#focal-dh.REF.lasocki.2011.48">Lasocki et al 2011</a>, <a class="bk_pop" href="#focal-dh.REF.vreeburg.2011.592">Vreeburg et al 2011</a>, <a class="bk_pop" href="#focal-dh.REF.yoshihashi.2011.550">Yoshihashi et al 2011</a>].</p><p>Affected males have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for a <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and are generally more mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> than females [<a class="bk_pop" href="#focal-dh.REF.grzeschik.2007.833">Grzeschik et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.wang.2007.836">Wang et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.lombardi.2011.723">Lombardi et al 2011</a>]. Of note, fathers with focal dermal hypoplasia are typically more mildly affected than their daughters [<a class="bk_pop" href="#focal-dh.REF.burgdorf.1981.273">Burgdorf et al 1981</a>], a discrepancy attributed to mosaicism in the males.</p></div><div id="focal-dh.Severe_Presentations"><h4>Severe Presentations</h4><p>Various phenotypes have been previously described as separate syndromes or potentially allelic conditions, but are now recognized to be within the spectrum of focal dermal hypoplasia.</p><p>Angioma serpiginosum was initially hypothesized to be allelic to focal dermal hypoplasia [<a class="bk_pop" href="#focal-dh.REF.blinkenberg.2007.543">Blinkenberg et al 2007</a>]. A <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>PORCN</i> was subsequently reported in one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual [<a class="bk_pop" href="#focal-dh.REF.houge.2008.1027">Houge et al 2008</a>], but this was later disputed and proposed to be a case of FDH instead of a case of angioma serpiginosum [<a class="bk_pop" href="#focal-dh.REF.happle.2009.881">Happle 2009</a>].</p><p>According to <a class="bk_pop" href="#focal-dh.REF.van_allen.1991.523">Van Allen &#x00026; Myhre [1991]</a>, Van Allen-Myhre syndrome was either a severe form of focal dermal hypoplasia or allelic to focal dermal hypoplasia. This has been confirmed in a report in which an individual with Van Allen-Myhre syndrome [<a class="bk_pop" href="#focal-dh.REF.hancock.2002.370">Hancock et al 2002</a>] was found to have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PORCN</i> [personal observation; case reported by <a class="bk_pop" href="#focal-dh.REF.wang.2007.836">Wang et al 2007</a>].</p><p>FDH with abdominal wall closure defects that are in the spectrum of pentalogy of Cantrell or limb-body wall complex anomaly have been reported [<a class="bk_pop" href="#focal-dh.REF.hancock.2002.370">Hancock et al 2002</a>, <a class="bk_pop" href="#focal-dh.REF.maas.2009.716">Maas et al 2009</a>, <a class="bk_pop" href="#focal-dh.REF.scott.2009.bcr0920080909">Scott et al 2009</a>, <a class="bk_pop" href="#focal-dh.REF.smigiel.2011.1102">Smigiel et al 2011</a>]. In some of these <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, <i>PORCN</i> pathogenic variants have been detected [<a class="bk_pop" href="#focal-dh.REF.maas.2009.716">Maas et al 2009</a>, <a class="bk_pop" href="#focal-dh.REF.lombardi.2011.723">Lombardi et al 2011</a>, <a class="bk_pop" href="#focal-dh.REF.smigiel.2011.1102">Smigiel et al 2011</a>]. Whether pathogenic variants in <i>PORCN</i> can cause <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> forms of these conditions has not been established.</p></div><div id="focal-dh.Pathology"><h4>Pathology</h4><p>Histopathologic and ultrastructural studies of the skin have shown the following:</p><ul><li class="half_rhythm"><div>A thinned dermis with disordered connective tissue and decreased number of collagen bundles and elastin fibers [<a class="bk_pop" href="#focal-dh.REF.kanitakis.2003.249">Kanitakis et al 2003</a>]</div></li><li class="half_rhythm"><div>Rests of mature adipose tissue scattered throughout the reticular and papillary dermis [<a class="bk_pop" href="#focal-dh.REF.howell.1989.237">Howell &#x00026; Freeman 1989</a>, <a class="bk_pop" href="#focal-dh.REF.del_carmen_boente.2007.181">del Carmen Boente et al 2007</a>]. Whether these represent herniation of fat into a thinned dermis or ectopic aggregation of fat within a dysplastic dermis is unclear [<a class="bk_pop" href="#focal-dh.REF.howell.1989.237">Howell &#x00026; Freeman 1989</a>].</div></li><li class="half_rhythm"><div>Verrucoid papillomas that resemble squamous papillomas with hyperplastic, stratified squamous epithelium overlying a fibrovascular core. Verrucoid papillomas lack the typical morphologic evidence of human papilloma virus infection and stain negative for Epstein-Barr virus RNA [<a class="bk_pop" href="#focal-dh.REF.rosen.2005.250">Rosen &#x00026; Bocklage 2005</a>].</div></li><li class="half_rhythm"><div>From biopsies from Blaschkoid streaks, findings of increased papillary dermal blood vessels, decreased thickness of the dermis, and adipocytes high in the dermis strongly point to the diagnosis of focal dermal hypoplasia [<a class="bk_pop" href="#focal-dh.REF.ko.2016.418">Ko et al 2016</a>].</div></li></ul></div></div><div id="focal-dh.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Information on <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> in focal dermal hypoplasia is limited.</p><p>Available data suggest that the level of <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> correlates with severity of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in some (<a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a>) cases [<a class="bk_pop" href="#focal-dh.REF.grzeschik.2007.833">Grzeschik et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.wang.2007.836">Wang et al 2007</a>].</p><p>Note: All females with deletions in <i>PORCN</i> have extremely skewed <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>, whereas females with a <a class="def" href="/books/n/gene/glossary/def-item/single-nucleotide-variant/">single-nucleotide variant</a> can have random or skewed X-chromosome inactivation [<a class="bk_pop" href="#focal-dh.REF.grzeschik.2007.833">Grzeschik et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.wang.2007.836">Wang et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.lombardi.2011.723">Lombardi et al 2011</a>].</p><p>Nearly all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males to date have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for a <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, with males being generally more mildly affected than females; however, some severely affected males have been reported [<a class="bk_pop" href="#focal-dh.REF.maas.2009.716">Maas et al 2009</a>, <a class="bk_pop" href="#focal-dh.REF.bornholdt.2009.e618">Bornholdt et al 2009</a>, <a class="bk_pop" href="#focal-dh.REF.lombardi.2011.723">Lombardi et al 2011</a>]. One notable exception is two brothers who were <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for an inherited novel <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant thought to contribute to <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> microphthalmia [<a class="bk_pop" href="#focal-dh.REF.brady.2015.551">Brady et al 2015</a>]. The phenotypic severity in female relatives harboring the same variant ranged from mild to unaffected, suggesting a probable <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</p></div><div id="focal-dh.Penetrance"><h3>Penetrance</h3><p>Focal dermal hypoplasia appears to be highly penetrant in females, but the phenotypic severity can occasionally be mitigated by skewed <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>.</p><p>Males are nearly always mosaic for a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> somatic <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and can be so mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> as to not come to medical attention until adulthood.</p></div><div id="focal-dh.Nomenclature"><h3>Nomenclature</h3><p>Focal dermal hypoplasia is also known by the following eponyms:</p><ul><li class="half_rhythm"><div>Goltz syndrome</div></li><li class="half_rhythm"><div>Goltz-Gorlin syndrome</div></li></ul><p>Note: Gorlin-Goltz syndrome is another name for <a href="/books/n/gene/bcns/">nevoid basal cell carcinoma syndrome</a>.</p><p>Note that not all individuals with the disorder focal dermal hypoplasia have focal areas of skin hypoplasia.</p></div><div id="focal-dh.Prevalence"><h3>Prevalence</h3><p>Focal dermal hypoplasia is an uncommon disorder with about 300 reported <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals worldwide [<a class="bk_pop" href="#focal-dh.REF.goltz.1992.1108">Goltz 1992</a>, <a class="bk_pop" href="#focal-dh.REF.tadini.2015">Tadini et al 2015</a>]. The exact prevalence is unknown.</p></div></div><div id="focal-dh.Genetically_Related_Allelic_Dis"><h2 id="_focal-dh_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>PORCN</i>.</p></div><div id="focal-dh.Differential_Diagnosis"><h2 id="_focal-dh_Differential_Diagnosis_">Differential Diagnosis</h2><p><a href="/books/n/gene/microph-lsd/"><b>Microphthalmia with linear skin defects</b></a>
<b>(MLS)</b> can have skin and ophthalmologic manifestations similar to FDH; however, limb and skeletal malformations are uncommon in MLS. MLS is caused by deletions and variants in <i>HCCS</i> [<a class="bk_pop" href="#focal-dh.REF.wimplinger.2006.878">Wimplinger et al 2006</a>]. MLS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner and mainly affects females as it is usually lethal in males.</p><p><a href="/books/n/gene/i-p/"><b>Incontinentia pigmenti</b></a>
<b>(IP)</b> is a disorder that affects the skin, hair, teeth, nails, eyes, and central nervous system. Characteristic skin lesions evolve through four stages: (I) blistering (birth to age ~4 months); (II) a wart-like rash (for several months); (III) swirling macular hyperpigmentation (age ~6 months into adulthood); (IV) linear hypopigmentation. Alopecia, hypodontia, abnormal tooth shape, and dystrophic nails are observed. Neovascularization of the retina, present in some individuals, predisposes to retinal detachment. Neurologic findings including cognitive delays / intellectual disability are occasionally seen. <i>IKBKG</i> (<i>NEMO</i>) is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with IP. IP is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner and is lethal in many males.</p><p><a href="/books/n/gene/aec/"><b><i>TP63</i>-related disorders</b></a> are characterized by a varying combinations of limb malformations (split-hand/foot malformation, syndactyly) and ectodermal findings (skin erosions, hypoplastic breast tissue, hypopigmentation of the skin, nail dysplasia, alopecia, dental abnormalities). However, the skin manifestations are typically not in a Blaschko distribution and ocular colobomas and microphthalmia are rare. These disorders are caused by <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>TP63</i>, affecting both males and females.</p><p><b>Oculocerebrocutaneous syndrome</b> (OMIM <a href="http://omim.org/entry/164180" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">164180</a>) is characterized by microphthalmia/anophthalmia, orbital cysts, linear skin pigmentation, and dermal hypoplasia. The condition predominantly affects males and can be distinguished from focal dermal hypoplasia by presence (in the former) of characteristic brain malformations including frontal polymicrogyria, periventricular nodular heterotopia, and agenesis of the corpus callosum [<a class="bk_pop" href="#focal-dh.REF.moog.2005.913">Moog et al 2005</a>]. No <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is causative has been identified.</p><p><a href="/books/n/gene/rts/"><b>Rothmund-Thomson syndrome</b></a>
<b>(RTS)</b> is characterized by poikiloderma; sparse hair, eyelashes, and/or eyebrows/lashes; small stature; skeletal and dental abnormalities; cataracts; and an increased risk for cancer, especially osteosarcoma. The skin is typically normal at birth; the rash of RTS develops between ages three and six months as erythema, swelling, and blistering on the face and subsequently spreads to the buttocks and extremities. The rash evolves over months to years into the chronic pattern of reticulated hypo- and hyperpigmentation, punctate atrophy, and telangiectases, collectively known as poikiloderma. Hyperkeratotic lesions occur in about one third of individuals. Skeletal abnormalities include dysplasias, absent or malformed bones (e.g., absent radii), osteopenia, and delayed bone formation. RTS is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>RECQL4</i> and is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><b>Other.</b> Papillomas of the genital and anal region are common and should not be confused with genital warts.</p></div><div id="focal-dh.Management"><h2 id="_focal-dh_Management_">Management</h2><div id="focal-dh.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with focal dermal hypoplasia, the following evaluations are recommended.</p><ul><li class="half_rhythm"><div><b>Ectodermal manifestations.</b> Evaluation by a dermatologist for identification of dermal aplasia or erosive skin that may benefit from treatment with dressings or lotion</div></li><li class="half_rhythm"><div><b>Papillomatosis</b></div><ul><li class="half_rhythm"><div>Evaluation by an otolaryngologist for evidence of laryngeal or peri-tonsillar verrucoid papillomas, which can cause obstructive sleep apnea</div></li><li class="half_rhythm"><div>Sleep study to evaluate for obstructive sleep apnea (often due to airway papillomas)</div></li></ul></li><li class="half_rhythm"><div><b>Limb and skeletal manifestations.</b> Chest x-ray to evaluate for costovertebral defects and evidence of diaphragmatic hernia</div></li><li class="half_rhythm"><div><b>Eye findings.</b> Eye examination to evaluate for iris colobomas, chorioretinal colobomas, nystagmus, strabismus, or cataracts</div></li><li class="half_rhythm"><div><b>Oral and dental findings</b></div><ul><li class="half_rhythm"><div>Evaluation by a cleft palate team if relevant</div></li><li class="half_rhythm"><div>Examination by a dentist beginning with the first teeth around age one year</div></li></ul></li><li class="half_rhythm"><div><b>Gastrointestinal and nutrition</b></div><ul><li class="half_rhythm"><div>Consideration of abdominal ultrasound examination to evaluate for diaphragmatic hernia</div></li><li class="half_rhythm"><div>Evaluation by a gastroenterologist if gastroesophageal reflux disease (GERD) is an issue</div></li></ul></li><li class="half_rhythm"><div><b>Renal and urogenital</b></div><ul><li class="half_rhythm"><div>Renal ultrasound examination to evaluate for structural anomalies of the kidneys and urinary collecting system</div></li><li class="half_rhythm"><div>Evaluation by a pediatric gynecologist prior to puberty. Imaging studies of the reproductive tract should be considered as anomalies can affect fertility.</div></li></ul></li><li class="half_rhythm"><div><b>Cognitive and psychological.</b> Hearing evaluation</div></li><li class="half_rhythm"><div><b>Other.</b> Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="focal-dh.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Skin.</b> For individuals with significant areas of dermal aplasia, regular care by a dermatologist and use of occlusive dressings and antibiotic creams may help prevent secondary infections as erosive lesions may be painful and pruritic, and therefore prone to infection. Some individuals report that lotion is helpful in managing pruritic erosions. Pulsed dye laser or other photodynamic therapy has been successful in managing excessive granulation tissue [<a class="bk_pop" href="#focal-dh.REF.alster.1995.143">Alster &#x00026; Wilson 1995</a>, <a class="bk_pop" href="#focal-dh.REF.liu.2012.324">Liu et al 2012</a>].</p><p>An individual with refractory exophytic granulation tissue received significant benefit from a combination of curettage and photodynamic therapy [<a class="bk_pop" href="#focal-dh.REF.mallipeddi.2006.228">Mallipeddi et al 2006</a>].</p><p>An adult individual with multiple cutaneous basal cell carcinomas has been reported. Whether this is more prevalent in FDH is currently unknown, but heightened surveillance and appropriate treatment for such lesions may be indicated [<a class="bk_pop" href="#focal-dh.REF.patrizi.2012.97">Patrizi et al 2012</a>].</p><p><b>Papillomatosis.</b> Verrucoid papillomas can cause significant morbidity, including breathing problems (which could reflect the presence of laryngeal and/or tracheal papillomas) and GERD symptomatology (which could reflect the presence of esophageal papillomas). When possible, individuals should be referred to an otolaryngologist or gastroenterologist depending on the anatomic location of the papillomas.</p><p>Symptomatic papillomas of the esophagus can be removed endoscopically [<a class="bk_pop" href="#focal-dh.REF.kashyap.2011.784">Kashyap et al 2011</a>] or with balloon-assisted radiofrequency ablation [<a class="bk_pop" href="#focal-dh.REF.bertani.2014.e404">Bertani et al 2014</a>]. Airway (hypopharyngeal, tonsillar, and tracheal) papillomas can be managed with surgery or laser therapy.</p><p><b>Skeletal.</b> Impaired functionality associated with syndactyly, oligodactyly, and split-hand/foot malformation may improve with occupational therapy, assistive devices, or surgical intervention.</p><p>Reduction defects of the long bones, such as transverse deficiency of distal radius/ulna or tibia/fibula, may be managed with prostheses as appropriate.</p><p>Camptodactyly often improves with physical and occupational therapy.</p><p>Individuals with scoliosis secondary to costovertebral defects should be referred to an orthopedist for routine monitoring and management.</p><p>Management of pain related to diastasis pubis with anti-inflammatory medications and/or physical therapy usually resolves the pain. Individuals with pain refractory to these interventions should consult an orthopedist.</p><p><b>Eye.</b> Colobomas of the eyelid may be repaired by an oculoplastic surgeon.</p><p>Iris colobomas can be aesthetically treated with colored contact lenses to give the appearance of a round pupil.</p><p>The photophobia that often accompanies iris colobomas can be reduced by use of tinted glasses.</p><p>Because retinal detachment leading to blindness is a potential complication of retinal coloboma, any acute changes in vision should be evaluated urgently by an ophthalmologist.</p><p>In patients with microphthalmia, an ocularist using prosthetic intervention can work to expand the palpebral fissures. Additional surgical corrections can be discussed with an oculoplastic surgeon.</p><p>Children with reduced vision may benefit from visual aids or other visual resources as part of an early intervention program to increase visual-spatial development.</p><p><b>Dental.</b> Regular care of a dentist and promotion of good oral hygiene, diet counseling, and consideration of fissure sealants are important to minimize the risk of dental caries [<a class="bk_pop" href="#focal-dh.REF.tejani.2005.67">Tejani et al 2005</a>, <a class="bk_pop" href="#focal-dh.REF.murakami.2011.e11">Murakami et al 2011</a>].</p><p>Abnormalities in the structure and number of teeth may cause dental malocclusion and dissatisfaction with the appearance of the teeth. Orthodontic care may be indicated when dental malocclusion is present. Composite veneers and other aesthetic procedures may be used to improve the appearance of abnormal teeth [<a class="bk_pop" href="#focal-dh.REF.tejani.2005.67">Tejani et al 2005</a>, <a class="bk_pop" href="#focal-dh.REF.murakami.2011.e11">Murakami et al 2011</a>].</p><p><b>Other.</b> Consultation with:</p><ul><li class="half_rhythm"><div>A pediatric surgeon for the treatment of diaphragmatic hernia and abdominal wall defects.</div></li><li class="half_rhythm"><div>A urologist or nephrologist for treatment of structural malformations of the kidneys and urinary collecting system and their sequelae. In individuals with structural renal malformations, standard measures are used to reduce risk for urinary tract infections.</div></li><li class="half_rhythm"><div>A developmental pediatrician for evaluation and management of behavioral problems, emotional lability, or withdrawn behaviors. Those with intellectual impairment or developmental delay should receive early intervention in occupational, speech, and physical therapies.</div></li></ul></div><div id="focal-dh.Prevention_of_Secondary_Complic"><h3>Prevention of Secondary Complications</h3><p>Preoperative evaluation by an otolaryngologist for hypopharyngeal and tonsillar papillomas [<a class="bk_pop" href="#focal-dh.REF.rhee.2006.1342">Rhee et al 2006</a>] is indicated prior to general anesthesia. Any papillomas that would complicate endotracheal intubation should be surgically removed or communicated to the anesthesiologist prior to the procedure.</p><p>Note: These lesions may change significantly over time, so the evaluation should be within a few months of the procedure. The papillomas may be friable and prone to bleeding; when papillomas are present, the airway must be handled as gently as possible (which may include fiberoptic bronchoscopy for intubation rather than direct laryngoscopy) [<a class="bk_pop" href="#focal-dh.REF.rhee.2006.1342">Rhee et al 2006</a>].</p></div><div id="focal-dh.Surveillance"><h3>Surveillance</h3><p>The following should be considered as part of routine medical care for individuals with focal dermal hypoplasia:</p><ul><li class="half_rhythm"><div><b>Skin.</b> Routine follow-up with a dermatologist to anticipate and manage common skin problems</div></li><li class="half_rhythm"><div><b>Papillomatosis</b></div><ul><li class="half_rhythm"><div>Monitoring for symptoms of gastroesophageal reflux disease and swallowing difficulties at routine health visits. When present, refer to an otolaryngologist for evaluation of possible verrucoid papillomas and management with surgical or laser therapy as needed.</div></li><li class="half_rhythm"><div>Routine monitoring for symptoms of obstructive sleep apnea (snoring, gasping, breathing pauses). If present, a sleep study should be performed [<a class="bk_pop" href="#focal-dh.REF.bostwick.2016.9">Bostwick et al 2016</a>].</div></li></ul></li><li class="half_rhythm"><div><b>Skeletal.</b> Routine physical examinations and/or spine radiographs to evaluate for scoliosis, particularly in individuals with costovertebral segmentation abnormalities</div></li><li class="half_rhythm"><div><b>Dental.</b> Regular examinations</div></li><li class="half_rhythm"><div><b>Other</b></div><ul><li class="half_rhythm"><div>Routine monitoring of growth and body composition to determine if early nutritional intervention is needed [<a class="bk_pop" href="#focal-dh.REF.motil.2016.29">Motil et al 2016</a>]</div></li><li class="half_rhythm"><div>Regular eye examinations to monitor for changes in visual acuity and risks for retinal detachment in individuals with retinal colobomas. Any acute changes in vision should be considered a medical emergency as retinal detachment can lead to total blindness.</div></li><li class="half_rhythm"><div>Routine screening of cognitive, emotional, behavioral, and adaptive ability, with appropriate referrals to therapeutic interventions as indicated [<a class="bk_pop" href="#focal-dh.REF.deidrick.2016.34">Deidrick et al 2016</a>]</div></li></ul></li></ul></div><div id="focal-dh.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Because some individuals with severe skin manifestations may have hypohidrosis (and thus be at increased risk for heat intolerance), care should be taken to prevent exposure to extreme heat.</p></div><div id="focal-dh.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#focal-dh.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="focal-dh.Pregnancy_Management"><h3>Pregnancy Management</h3><p>For <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> women, management of pregnancy should be guided by standard obstetric principles taking into account potential complications of FDH. Skeletal abnormalities including scoliosis or diastasis pubis may be present in some affected women, and may affect delivery management. Women with significant scoliosis will benefit from evaluation of respiratory status and feasibility of epidural analgesia. Obstetricians should be aware that verrucous papillomas in genital areas in women with FDH are unlikely to be viral in origin and thus, there is no risk for transmission to the newborn during vaginal delivery.</p></div><div id="focal-dh.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="focal-dh.Genetic_Counseling"><h2 id="_focal-dh_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="focal-dh.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Focal dermal hypoplasia (FDH) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p><p>Females account for 90% of individuals with FDH; they may have <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> or mosaic pathogenic variants in <i>PORCN</i>. Males account for 10% of individuals with FDH; nearly all live-born <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males who have had molecular testing are mosaic for a <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#focal-dh.REF.lombardi.2011.723">Lombardi et al 2011</a>]. It is presumed that non-mosaic, <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> males are not viable.</p></div><div id="focal-dh.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Approximately 95% of females with FDH have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Approximately 5% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females have inherited a <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a parent, usually the mother; such women may be more, equally, or less affected than their mothers [<a class="bk_pop" href="#focal-dh.REF.wang.2007.836">Wang et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.shimaoka.2009.181">Shimaoka et al 2009</a>].</div><ul><li class="half_rhythm"><div>Less frequently, an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> female may have inherited the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a father mosaic for a <i>PORCN</i> pathogenic variant [<a class="bk_pop" href="#focal-dh.REF.wang.2007.836">Wang et al 2007</a>]; fathers with FDH are typically more mildly affected than their daughters [<a class="bk_pop" href="#focal-dh.REF.burgdorf.1981.273">Burgdorf et al 1981</a>].</div></li></ul></li><li class="half_rhythm"><div><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> An apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</div><ul><li class="half_rhythm"><div>If the <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the parent who has manifestations of FDH is appropriate.</div></li><li class="half_rhythm"><div>If neither parent has clinical manifestations of FDH, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of both parents should be considered because: (1) the father or mother may have low-level <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> or (2) the mother may be a mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> secondary to extremely favorable skewing of <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>.</div></li></ul></li><li class="half_rhythm"><div><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Live-born <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males are rare and nearly always have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>, presumably postzygotic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The mother of a severely affected male should be examined for subtle features of FDH. Maternal testing is indicated as two <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> males have been reported as offspring of a seemingly asymptomatic mother with a presumed <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> pathogenic variant and favorable skewing of <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> [<a class="bk_pop" href="#focal-dh.REF.brady.2015.551">Brady et al 2015</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs of a female proband depends on the genetic status of the mother and father:</div><ul><li class="half_rhythm"><div>If the <b>mother</b> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk at conception of a sib inheriting the variant is 50%. However, the risk at delivery that a sib will be affected is lower than 50% because nearly all male conceptuses with the variant are presumed to be spontaneously aborted. The expected ratio in live-born sibs is 33% unaffected females, 33% affected females, and 33% unaffected males.</div></li><li class="half_rhythm"><div>If the <b>father</b> has the <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to female sibs of inheriting the variant at conception is as high as 100% depending on the level of <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> in the father's <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>. Male sibs are not at risk of inheriting the pathogenic variant from their father.</div></li></ul></li><li class="half_rhythm"><div><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Because evidence from both molecular studies and clinical reports indicates that nearly all live-born males are mosaic for a postzygotic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male is similar to the population risk for this disorder.</div></li></ul><p><b>Offspring of <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the offspring of females with FDH must take into consideration the presumed lethality to males during gestation.</div><ul><li class="half_rhythm"><div>At conception, the risk that the <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be transmitted is 50%; however, most male conceptuses with the <i>PORCN</i> variant are presumed to be spontaneously aborted. Thus, at delivery the expected ratio of offspring is 33% unaffected females, 33% <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females, and 33% unaffected males.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> female is mosaic for a <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to her offspring is as high as 50%, depending on the level of <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> in her <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>.</div></li></ul></li><li class="half_rhythm"><div><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Males with focal dermal hypoplasia have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for a <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div><ul><li class="half_rhythm"><div>The risk to an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male of having an affected daughter is as high as 100% depending on the level of <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> in his <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>.</div></li><li class="half_rhythm"><div>Males do not transmit their X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> to their sons and thus their sons are not at risk of inheriting the <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul></li></ul><p><b>Other family members.</b> If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> also has a <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, her female family members may also be at risk of having the pathogenic variant (asymptomatic or symptomatic) and her father may be at risk of being mosaic for the pathogenic variant.</p></div><div id="focal-dh.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="focal-dh.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for FDH are possible.</p></div></div><div id="focal-dh.Resources"><h2 id="_focal-dh_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Ectodermal Dysplasia Society</b></div><div>108 Charlton Lane</div><div>Cheltenham Gloucestershire GL53 9EA</div><div>United Kingdom</div><div><b>Phone:</b> 01242 261332</div><div><b>Email:</b> diana@ectodermaldysplasia.org</div><div><a href="http://www.ectodermaldysplasia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ectodermaldysplasia.org</a></div></li><li class="half_rhythm"><div><b>National Foundation for Ectodermal Dysplasias (NFED)</b></div><div>410 East Main Street</div><div>PO Box 114</div><div>Mascoutah IL 62258-0114</div><div><b>Phone:</b> 618-566-2020</div><div><b>Fax:</b> 618-566-4718</div><div><b>Email:</b> info@nfed.org</div><div><a href="http://www.nfed.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nfed.org</a></div></li><li class="half_rhythm"><div><b>Ectodermal Dysplasias International Registry</b></div><div>National Foundation for Ectodermal Dysplasias</div><div>410 East Main Street</div><div>Mascoutah IL 62258</div><div><b>Phone:</b> 618-566-2020</div><div><b>Fax:</b> 618-566-4718</div><div><b>Email:</b> info@nfed.org</div><div><a href="https://nfed.patientcrossroads.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ectodermal Dysplasias International Registry</a></div></li></ul></div><div id="focal-dh.Molecular_Genetics"><h2 id="_focal-dh_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="focal-dh.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Focal Dermal Hypoplasia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1543/table/focal-dh.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__focal-dh.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_focal-dh.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_focal-dh.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_focal-dh.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_focal-dh.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_focal-dh.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_focal-dh.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_focal-dh.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/64840" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PORCN</i></a></td><td headers="hd_b_focal-dh.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=64840" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xp11<wbr style="display:inline-block"></wbr>​.23</a></td><td headers="hd_b_focal-dh.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9H237" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Protein-serine O-palmitoleoyltransferase porcupine</a></td><td headers="hd_b_focal-dh.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/PORCN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PORCN @ LOVD</a></td><td headers="hd_b_focal-dh.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PORCN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PORCN</a></td><td headers="hd_b_focal-dh.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PORCN[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PORCN</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="focal-dh.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="focal-dh.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Focal Dermal Hypoplasia (<a href="/omim/300651,305600" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1543/table/focal-dh.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__focal-dh.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300651" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300651</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PORCUPINE O-ACYLTRANSFERASE; PORCN</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/305600" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">305600</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FOCAL DERMAL HYPOPLASIA; FDH</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>PORCN</i> has 15 exons, 14 of which are coding exons. It undergoes alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>, resulting in five transcript variants. See <a href="/books/NBK1543/#focal-dh.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> Pathogenic variants in <i>PORCN</i> include <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants as well as partial- and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions. Deletions may include flanking genes; however, no additional clinical features were reported [<a class="bk_pop" href="#focal-dh.REF.grzeschik.2007.833">Grzeschik et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.wang.2007.836">Wang et al 2007</a>]. Nearly all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males to date have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for a <i>PORCN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#focal-dh.REF.grzeschik.2007.833">Grzeschik et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.wang.2007.836">Wang et al 2007</a>, <a class="bk_pop" href="#focal-dh.REF.lombardi.2011.723">Lombardi et al 2011</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>PORCN</i> encodes the human homolog of <i>Drosophila</i> porcupine [<a class="bk_pop" href="#focal-dh.REF.caricasole.2002.147">Caricasole et al 2002</a>]. The gene product, human protein-serine O-palmitoleoyltransferase porcupine, has five <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> that result from alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> and is expressed in a wide variety of tissues.</p><p>In model organisms, porcupine has been shown to be required for secretion and signaling of most WNT proteins from WNT-producing cells [<a class="bk_pop" href="#focal-dh.REF.van_amerongen.2009.3205">van Amerongen &#x00026; Nusse 2009</a>, <a class="bk_pop" href="#focal-dh.REF.chen.2012.e52948">Chen et al 2012</a>, <a class="bk_pop" href="#focal-dh.REF.clevers.2012.1192">Clevers &#x00026; Nusse 2012</a>] and may play a role in fine-tuning WNT protein levels. WNT signaling is required for induction, proliferation, morphogenesis, and maintenance of most organs. WNTs are important secreted morphogens that interact with receptors and co-receptors on target cells. Activation of the WNT pathway is important for normal development [<a class="bk_pop" href="#focal-dh.REF.clevers.2012.1192">Clevers &#x00026; Nusse 2012</a>] and may be required to activate additional non-canonical Wnt signaling [<a class="bk_pop" href="#focal-dh.REF.proffitt.2012.34167">Proffitt &#x00026; Virshup 2012</a>]. Wnt-3a is retained in the endoplasmic reticulum of cultured cells when <i>Porcn</i> is inactivated [<a class="bk_pop" href="#focal-dh.REF.takada.2006.791">Takada et al 2006</a>, <a class="bk_pop" href="#focal-dh.REF.clevers.2012.1192">Clevers &#x00026; Nusse 2012</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Focal dermal hypoplasia is caused by <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> pathogenic variants and deletions of <i>PORCN</i>.</p><p>Loss of function of orthologs in mouse cells and <i>Drosophila</i> results in failure of WNT proteins to be secreted from the endoplasmic reticulum in WNT-producing cells, with defective downstream WNT signaling [<a class="bk_pop" href="#focal-dh.REF.tanaka.2000.4300">Tanaka et al 2000</a>, <a class="bk_pop" href="#focal-dh.REF.takada.2006.791">Takada et al 2006</a>]. Inactivation of <i>Porcn</i> in mouse embryos has resulted in early embryonic lethality and revealed that it is required for gastrulation and normal development of mesoderm and ectoderm-derived structures [<a class="bk_pop" href="#focal-dh.REF.barrott.2011.12752">Barrott et al 2011</a>, <a class="bk_pop" href="#focal-dh.REF.biechele.2011.275">Biechele et al 2011</a>, <a class="bk_pop" href="#focal-dh.REF.liu.2012.324">Liu et al 2012</a>]. Conditional inactivation of <i>Porcn</i> in developing skin causes alopecia because hair follicles do not form [<a class="bk_pop" href="#focal-dh.REF.liu.2012.324">Liu et al 2012</a>], and in developing limbs causes skeletal defects reminiscent of those seen in persons with FDH [<a class="bk_pop" href="#focal-dh.REF.barrott.2011.12752">Barrott et al 2011</a>, <a class="bk_pop" href="#focal-dh.REF.liu.2012.324">Liu et al 2012</a>].</p><p>The new mouse models will be helpful in the future to further understand the normal function of porcupine and to test potential new therapies for those symptoms that are progressive or first present after birth.</p></div><div id="focal-dh.References"><h2 id="_focal-dh_References_">References</h2><div id="focal-dh.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.adeyemifowode.2016.64">Adeyemi-Fowode OA, Mansouri R, Dietrich JE. Gynecologic findings in Goltz syndrome: a case series. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2016;<span class="ref-vol">172C</span>:64–6.</span> [<a href="/pubmed/27001927" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27001927</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.alkindi.2013.476">Alkindi S, Battin M, Aftimos S, Purvis D. Focal dermal hypoplasia due to a novel pathogenic variant in a boy with Klinefelter syndrome. <span><span class="ref-journal">Pediatr Dermatol. </span>2013;<span class="ref-vol">30</span>:476–9.</span> [<a href="/pubmed/23131169" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23131169</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.almeida.1988.917">Almeida L, Anyane-Yeboa K, Grossman M, Rosen T. Myelomeningocele, Arnold-Chiari anomaly and hydrocephalus in focal dermal hypoplasia. <span><span class="ref-journal">Am J Med Genet. </span>1988;<span class="ref-vol">30</span>:917–23.</span> [<a href="/pubmed/3189414" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3189414</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.alster.1995.143">Alster TS, Wilson F. Focal dermal hypoplasia (Goltz's syndrome). Treatment of cutaneous lesions with the 585-nm flashlamp-pumped pulsed dye laser. <span><span class="ref-journal">Arch Dermatol. </span>1995;<span class="ref-vol">131</span>:143–4.</span> [<a href="/pubmed/7857109" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7857109</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.altschuler.2012.500">Altschuler EL, Yoon RS, Dentico R, Liporace FA. Spontaneous patella fracture presenting as osteomyelitis in focal dermal hypoplasia. <span><span class="ref-journal">Knee. </span>2012;<span class="ref-vol">19</span>:500–3.</span> [<a href="/pubmed/22000280" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22000280</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.asano.2013.120">Asano M, Fujimura T, Wakusawa C, Aoki Y, Matsubara Y, Aiba S. A case of almost unilateral focal dermal hypoplasia resulting from a novel pathogenic variant in the PORCN gene. <span><span class="ref-journal">Acta Derm Venereol. </span>2013;<span class="ref-vol">93</span>:120–1.</span> [<a href="/pubmed/22735390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22735390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.ascherman.2002.469">Ascherman JA, Knowles SL, Troutman KC. Extensive facial clefting in a patient with Goltz syndrome: multidisciplinary treatment of a previously unreported association. <span><span class="ref-journal">Cleft Palate Craniofac J. </span>2002;<span class="ref-vol">39</span>:469–73.</span> [<a href="/pubmed/12071796" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12071796</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.balmer.2004.686">Balmer R, Cameron AC, Ad&#x000e8;s L, Aldred MJ. Enamel defects and lyonization in focal dermal hypoplasia. <span><span class="ref-journal">Oral Surg Oral Med Oral Pathol Oral Radiol Endod. </span>2004;<span class="ref-vol">98</span>:686–91.</span> [<a href="/pubmed/15583541" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15583541</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.barrott.2011.12752">Barrott JJ, Cash GM, Smith AP, Barrow JR, Murtaugh LC. Deletion of mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of human focal dermal hypoplasia/Goltz syndrome. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2011;<span class="ref-vol">108</span>:12752–7.</span> [<a href="/pmc/articles/PMC3150921/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3150921</span></a>] [<a href="/pubmed/21768372" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21768372</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.bertani.2014.e404">Bertani H, Mirante VG, Caruso A, Manno M, Brancaccio ML, Conigliaro R. Successful treatment of diffuse esophageal papillomatosis with balloon-assisted radiofrequency ablation in a patient with Goltz syndrome. <span><span class="ref-journal">Endoscopy. </span>2014;<span class="ref-vol">46</span>:E404–5.</span> [<a href="/pubmed/25314164" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25314164</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.biechele.2011.275">Biechele S, Cox BJ, Rossant J. Porcupine homolog is required for canonical Wnt signaling and gastrulation in mouse embryos. <span><span class="ref-journal">Dev Biol. </span>2011;<span class="ref-vol">355</span>:275–85.</span> [<a href="/pubmed/21554866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21554866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.blinkenberg.2007.543">Blinkenberg EO, Brendehaug A, Sandvik AK, Vatne O, Hennekam RCM, Houge G. Angioma serpiginosum with oesophageal papillomatiosis is an X-linked dominant condition that maps to Xp11.3-Xq12. <span><span class="ref-journal">Eur J Hum Genet. </span>2007;<span class="ref-vol">15</span>:543–7.</span> [<a href="/pubmed/17342156" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17342156</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.bornholdt.2009.e618">Bornholdt D, Oeffner F, K&#x000f6;nig A, Happle R, Alanay Y, Ascherman J, Benke PJ, Boente Mdel C, van der Burgt I, Chassaing N, Ellis I, Francisco CR, Della Giovanna P, Hamel B, Has C, Heinelt K, Janecke A, Kastrup W, Loeys B, Lohrisch I, Marcelis C, Mehraein Y, Nicolas ME, Pagliarini D, Paradisi M, Patrizi A, Piccione M, Piza-Katzer H, Prager B, Prescott K, Strien J, Utine GE, Zeller MS, Grzeschik KH. PORCN mutations in focal dermal hypoplasia: coping with lethality. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:E618–28.</span> [<a href="/pubmed/19309688" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19309688</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.bostwick.2016.9">Bostwick B, Fang P, Patel A, Sutton VR. Phenotypic and molecular characterization of focal dermal hypoplasia in 18 individuals. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2016;<span class="ref-vol">172C</span>:9–20.</span> [<a href="/pubmed/26853229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26853229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.brady.2015.551">Brady PD, Van Esch H, Fieremans N, Froyen G, Slavotinek A, Deprest J, Devriendt K, Vermeesch JR. Expanding the phenotypic spectrum of PORCN variants in two males with syndromic microphthalmia. <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>:551–4.</span> [<a href="/pmc/articles/PMC4666577/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4666577</span></a>] [<a href="/pubmed/25026905" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25026905</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.bree.2016.44">Bree AF, Grange DK, Hicks MJ, Goltz RW. Dermatologic findings of focal dermal hypoplasia (Goltz syndrome). <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2016;<span class="ref-vol">172C</span>:44–51.</span> [<a href="/pubmed/26858134" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26858134</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.brinson.1987.1177">Brinson RR, Schuman BM, Mills LR, Thigpen S, Freedman S. Multiple squamous papillomas of the esophagus associated with Goltz syndrome. <span><span class="ref-journal">Am J Gastroenterol. </span>1987;<span class="ref-vol">82</span>:1177–9.</span> [<a href="/pubmed/3673998" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3673998</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.burgdorf.1981.273">Burgdorf WHC, Dick GF, Soderberg MD, Goltz RW. Focal dermal hypoplasia in a father and daughter. <span><span class="ref-journal">J Am Acad Dermatol. </span>1981;<span class="ref-vol">4</span>:273–7.</span> [<a href="/pubmed/7217396" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7217396</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.caricasole.2002.147">Caricasole A, Ferraro T, Rimland JM, Terstappen GC. Molecular cloning and initial characterization of the MG61/PORC gene, the human homologue of the Drosophila segment polarity gene Porcupine. <span><span class="ref-journal">Gene. </span>2002;<span class="ref-vol">288</span>:147–57.</span> [<a href="/pubmed/12034504" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12034504</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.chen.2012.e52948">Chen D, Li Y, Zhou Z, Xing Y, Zhong Y, Zou X, Tian W, Zhang C. Synergistic inhibition of Wnt pathway by HIF-1&#x003b1; and osteoblast-specific transcription factor osterix (Osx) in osteoblasts. <span><span class="ref-journal">PLoS One. </span>2012;<span class="ref-vol">7</span>:e52948.</span> [<a href="/pmc/articles/PMC3531395/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3531395</span></a>] [<a href="/pubmed/23300831" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23300831</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.clevers.2012.1192">Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. <span><span class="ref-journal">Cell. </span>2012;<span class="ref-vol">149</span>:1192–1205.</span> [<a href="/pubmed/22682243" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22682243</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.deidrick.2016.34">Deidrick KK, Early M, Constance J, Stein M, Fete TJ. Cognitive and psychological functioning in focal dermal hypoplasia. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2016;<span class="ref-vol">172C</span>:34–40.</span> [<a href="/pubmed/26818018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26818018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.del_carmen_boente.2007.181">del Carmen Boente M, Asial RA, Winik BC. Focal dermal hypoplasia: ultrastructural abnormalities of the connective tissue. <span><span class="ref-journal">J Cutan Pathol. </span>2007;<span class="ref-vol">34</span>:181–7.</span> [<a href="/pubmed/17244031" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17244031</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.dias.2010.305">Dias C, Basto J, Pinho O, Barbedo C, Martins M, Bornholdt D, Fortuna A, Grzeschik KH, Lima M. A nonsense porcn pathogenic variant in severe focal dermal hypoplasia with natal teeth. <span><span class="ref-journal">Fetal Pediatr Pathol. </span>2010;<span class="ref-vol">29</span>:305–13.</span> [<a href="/pubmed/20704476" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20704476</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.fernandes.2010.709">Fernandes PH, Wen S, Sutton VR, Ward PA, Van den Veyver IB, Fang P. PORCN pathogenic variants and variants identified in patients with focal dermal hypoplasia through diagnostic gene sequencing. <span><span class="ref-journal">Genet Test Mol Biomarkers. </span>2010;<span class="ref-vol">14</span>:709–13.</span> [<a href="/pubmed/20854095" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20854095</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.froyen.2009.535">Froyen G, Govaerts K, Van Esch H, Verbeeck J, Tuomi ML, Heikkil&#x000e4; H, Torniainen S, Devriendt K, Fryns JP, Marynen P, J&#x000e4;rvel&#x000e4; I, Ala-Mello S. Novel PORCN mutations in focal dermal hypoplasia. <span><span class="ref-journal">Clin Genet. </span>2009;<span class="ref-vol">76</span>:535–43.</span> [<a href="/pubmed/19863546" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19863546</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.gisseman.2016.59">Gisseman JD, Herce HH. Ophthalmologic manifestations of focal dermal hypoplasia (Goltz syndrome): a case series of 18 patients. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2016;<span class="ref-vol">172C</span>:59–63.</span> [<a href="/pubmed/27001926" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27001926</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.goltz.1970.1">Goltz RW, Henderson RR, Hitch JM, Ott JE. Focal dermal hypoplasia syndrome. A review of the literature and report of two cases. <span><span class="ref-journal">Arch Dermatol. </span>1970;<span class="ref-vol">101</span>:1–11.</span> [<a href="/pubmed/5416790" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5416790</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.goltz.1992.1108">Goltz RW. Focal dermal hypoplasia syndrome. An update. <span><span class="ref-journal">Arch Dermatol. </span>1992;<span class="ref-vol">128</span>:1108–11.</span> [<a href="/pubmed/1497368" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1497368</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.gorlin.1963.421">Gorlin RJ, Meskin LH, Peterson WC, Goltz RW. Focal dermal hypoplasia syndrome. <span><span class="ref-journal">Acta Derm Venereol. </span>1963;<span class="ref-vol">43</span>:421–40.</span> [<a href="/pubmed/14051108" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14051108</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.grzeschik.2007.833">Grzeschik KH, Bornjoldt D, Oeffner F, K&#x000f6;nig A, del Carmen Boente M, Enders H, Hertl M, Grasshoff U, H&#x000f6;fling K, Oji V, Paradisi M, Schuchardt C, Szalai Z, Tadini G, Traupe H, Happle R. Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:833–5.</span> [<a href="/pubmed/17546031" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17546031</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.hancock.2002.370">Hancock S, Pryde P, Fong C, Brazy JE, Stewart K, Favour A, Pauli RM. Probable identity of Goltz syndrome and Van Allen-Myhre syndrome: evidence from phenotypic evolution. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">110</span>:370–9.</span> [<a href="/pubmed/12116212" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12116212</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.happle.2009.881">Happle R. Angioma serpiginosum is not caused by PORCN pathogenic variants. <span><span class="ref-journal">Eur J Hum Genet. </span>2009;<span class="ref-vol">17</span>:881–2.</span> [<a href="/pmc/articles/PMC2986492/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2986492</span></a>] [<a href="/pubmed/19337307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19337307</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.houge.2008.1027">Houge G, Oeffner F, Grzeschik KH. An Xp11.23 deletion containing PORCN may also cause angioma serpiginosum, a cosmetic skin disease associated with extreme skewing of X-inactivation. <span><span class="ref-journal">Eur J Hum Genet. </span>2008;<span class="ref-vol">16</span>:1027–8.</span> [<a href="/pubmed/18478042" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18478042</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.howell.1989.237">Howell JB, Freeman RG. Cutaneous defects of focal dermal hypoplasia: an ectomesodermal dysplasia syndrome. <span><span class="ref-journal">J Cutan Pathol. </span>1989;<span class="ref-vol">16</span>:237–58.</span> [<a href="/pubmed/2592623" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2592623</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.joannides.1983.684">Joannides T, Pringle JAS, Shaw DG, Godlee JN, Kemp HB. Giant cell tumour of bone in focal dermal hypoplasia. <span><span class="ref-journal">Br J Radiol. </span>1983;<span class="ref-vol">56</span>:684–5.</span> [<a href="/pubmed/6883033" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6883033</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.kanemura.2011.135">Kanemura H, Hatakeyama K, Sugita K, Aihara M. Epilepsy in a patient with focal dermal hypoplasia. <span><span class="ref-journal">Pediatric neurology. </span>2011;<span class="ref-vol">44</span>:135–8.</span> [<a href="/pubmed/21215914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21215914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.kanitakis.2003.249">Kanitakis J, Souillet AL, Butnaru C, Claudy A. Melanocyte stimulation in focal dermal hypoplasia with unusual pigmented skin lesions: a histologic and immunohistochemical study. <span><span class="ref-journal">Pediatr Dermatol. </span>2003;<span class="ref-vol">20</span>:249–53.</span> [<a href="/pubmed/12787276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12787276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.kashyap.2011.784">Kashyap P, Sweetser S, Farrugia G. Esophageal papillomas and skin abnormalities. Focal dermal hypoplasia (Goltz syndrome) manifesting with esophageal papillomatosis. <span><span class="ref-journal">Gastroenterology. </span>2011;<span class="ref-vol">140</span>:784.</span> [<a href="/pubmed/21272558" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21272558</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.kilmer.1993.839">Kilmer SL, Grix AW Jr, Isseroff RR. Focal dermal hypoplasia: four cases with widely varying presentations. <span><span class="ref-journal">J Am Acad Dermatol. </span>1993;<span class="ref-vol">28</span>:839–43.</span> [<a href="/pubmed/8491876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8491876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.ko.2016.418">Ko CJ, Antaya RJ, Zubek A, Craiglow B, Damsky W, Galan A, McNiff JM. Revisiting histopathologic findings in Goltz syndrome. <span><span class="ref-journal">J Cutan Pathol. </span>2016;<span class="ref-vol">43</span>:418–21.</span> [<a href="/pubmed/26956940" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26956940</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.lasocki.2011.48">Lasocki AL, Stark Z, Orchard D. A case of mosaic Goltz syndrome (focal dermal hypoplasia) in a male patient. <span><span class="ref-journal">Australas J Dermatol. </span>2011;<span class="ref-vol">52</span>:48–51.</span> [<a href="/pubmed/21332693" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21332693</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.liu.2012.324">Liu J, Hsu PT, VanderWielen BA, Teng JM. Treatment of recalcitrant excessive granulation tissue with photodynamic therapy in an eight-year-old patient with focal dermal hypoplasia syndrome. <span><span class="ref-journal">Pediatr Dermatol. </span>2012;<span class="ref-vol">29</span>:324–6.</span> [<a href="/pubmed/21995324" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21995324</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.lombardi.2011.723">Lombardi MP, Bulk S, Celli J, Lampe A, Gabbett MT, Ousager LB, van der Smagt JJ, Soller M, Stattin EL, Mannens MA, Smigiel R, Hennekam RC. Pathogenic variant update for the PORCN gene. <span><span class="ref-journal">Hum Mutat. </span>2011;<span class="ref-vol">32</span>:723–8.</span> [<a href="/pubmed/21472892" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21472892</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.lopezporras.2011.158">Lopez-Porras RF, Arroyo C, Soto-Vega E. Focal dermal hypoplasia with uterus bicornis and renal ectopia: case report and review of the literature. <span><span class="ref-journal">Case Rep Dermatol. </span>2011;<span class="ref-vol">3</span>:158–63.</span> [<a href="/pmc/articles/PMC3177835/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3177835</span></a>] [<a href="/pubmed/21941481" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21941481</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.maalouf.2012.85">Maalouf D, Megarbane H, Chouery E, Nasr J, Badens C, Lacoste C, Grzeschik KH, Megarbane A. A novel pathogenic variant in the PORCN gene underlying a case of almost unilateral focal dermal hypoplasia. <span><span class="ref-journal">Arch Dermatol. </span>2012;<span class="ref-vol">148</span>:85–8.</span> [<a href="/pubmed/22250236" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22250236</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.maas.2009.716">Maas SM, Lombardi MP, van Essen AJ, Wakeling EL, Castle B, Temple IK, Kumar VK, Writzl K, Hennekam RC. Phenotype and genotype in 17 patients with Goltz-Gorlin syndrome. <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:716–20.</span> [<a href="/pubmed/19586929" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19586929</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.mallipeddi.2006.228">Mallipeddi R, Chaudhry SI, Darley CR, Kurwa HA. A case of focal dermal hypoplasia (Goltz) syndrome with exophytic granulation tissue treated by curettage and photodynamic therapy. <span><span class="ref-journal">Clin Exp Dermatol. </span>2006;<span class="ref-vol">31</span>:228–31.</span> [<a href="/pubmed/16487098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16487098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.moog.2005.913">Moog U, Jones MC, Bird LM, Dobyns WB. Oculocerebrocutaneous syndrome: the brain malformation defines a core phenotype. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:913–21.</span> [<a href="/pmc/articles/PMC1735958/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735958</span></a>] [<a href="/pubmed/15879499" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15879499</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.motil.2016.29">Motil KJ, Fete M, Fete TJ. Growth, nutritional, and gastrointestinal aspects of focal dermal hypoplasia (Goltz-Gorlin syndrome). <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2016;<span class="ref-vol">172C</span>:29–33.</span> [<a href="/pubmed/27001925" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27001925</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.murakami.2011.e11">Murakami C, de Oliveira Lira Ortega A, Guimaraes AS, Goncalves-Bittar D, Bonecker M, Ciamponi AL. Focal dermal hypoplasia: a case report and literature review. <span><span class="ref-journal">Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. </span>2011;<span class="ref-vol">112</span>:e11–8.</span> [<a href="/pubmed/21684779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21684779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.patrizi.2012.97">Patrizi A, Tabanelli M, Grzeschik KH, Misciali C, Neri I, Happle R. Multiple basal cell carcinomas in a 38-year-old woman with Goltz syndrome. <span><span class="ref-journal">Dermatology. </span>2012;<span class="ref-vol">224</span>:97–100.</span> [<a href="/pubmed/22414489" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22414489</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.proffitt.2012.34167">Proffitt KD, Virshup DM. Precise regulation of porcupine activity is required for physiological Wnt signaling. <span><span class="ref-journal">J Biol Chem. </span>2012;<span class="ref-vol">287</span>:34167–78.</span> [<a href="/pmc/articles/PMC3464525/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3464525</span></a>] [<a href="/pubmed/22888000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22888000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.reddy.2009.e71">Reddy J, Laufer MR. Congenital anomalies of the female reproductive tract in a patient with Goltz syndrome. <span><span class="ref-journal">J Pediatr Adolesc Gynecol. </span>2009;<span class="ref-vol">22</span>:e71–2.</span> [<a href="/pubmed/19646662" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19646662</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.rhee.2006.1342">Rhee KY, Baek RM, Ahn KJ. Airway management in a patient with focal dermal hypoplasia. <span><span class="ref-journal">Anesth Analg. </span>2006;<span class="ref-vol">103</span>:1342.</span> [<a href="/pubmed/17056997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17056997</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.rosen.2005.250">Rosen SA, Bocklage T. Mucocutaneous squamous papilloma with reactive lymphoid hyperplasia in two patients with focal dermal hypoplasia. <span><span class="ref-journal">Pediatr Dev Pathol. </span>2005;<span class="ref-vol">8</span>:250–2.</span> [<a href="/pubmed/15747104" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15747104</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.scott.2009.bcr0920080909">Scott RW, Pivnick EK, Dowell SH, Eubanks JW, Huang EY, Van den Veyver IB, Wang X. Goltz syndrome: report of two severe cases. <span><span class="ref-journal">BMJ Case Rep. </span>2009;<span class="ref-vol">2009</span>:bcr0920080909.</span> [<a href="/pmc/articles/PMC3028403/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3028403</span></a>] [<a href="/pubmed/21686566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21686566</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.selzer.1974.714">Selzer G, David R, Revach M, Cvibah TJ, Fried A. Goltz syndrome with multiple giant-cell tumor-like lesions in bones. <span><span class="ref-journal">Ann Intern Med. </span>1974;<span class="ref-vol">80</span>:714–7.</span> [<a href="/pubmed/4364933" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4364933</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.shimaoka.2009.181">Shimaoka Y, Hatamochi A, Hamasaki Y, Shimura N, Arisaka O, Imai Y, Yamazaki S. Severe focal dermal hypoplasia in a female patient transmitted from a mildly affected mother. <span><span class="ref-journal">J Dermatol. </span>2009;<span class="ref-vol">36</span>:181–3.</span> [<a href="/pubmed/19335698" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19335698</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.smigiel.2011.1102">Smigiel R, Jakubiak A, Lombardi MP, Jaworski W, Slezak R, Patkowski D, Hennekam RC. Co-occurrence of severe Goltz-Gorlin syndrome and pentalogy of Cantrell - case report and review of the literature. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:1102–5.</span> [<a href="/pubmed/21484999" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21484999</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.smith.2016.41">Smith A, Hunt TR 3rd. The orthopedic characterization of Goltz syndrome. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2016;<span class="ref-vol">172C</span>:41–3.</span> [<a href="/pubmed/26867035" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26867035</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.suskan.1990.283">Suskan E, K&#x000fc;rk&#x000e7;&#x000fc;o&#x0011f;lu N, Uluo&#x0011f;lu O. Focal dermal hypoplasia (Goltz syndrome) with horseshoe kidney abnormality. <span><span class="ref-journal">Pediatr Dermatol. </span>1990;<span class="ref-vol">7</span>:283–6.</span> [<a href="/pubmed/2080123" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2080123</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.tadini.2015">Tadini G, Brena M, Gelmetti C, Pezzani L. Goltz syndrome. In: <em>Atlas of Genodermatoses.</em> 2 ed. CRC Press; 2015:274-5.</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.takada.2006.791">Takada R, Satomi Y, Kurata T, Ueno N, Norioka S, Kondoh H, Takao T, Takada S. Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. <span><span class="ref-journal">Dev Cell. </span>2006;<span class="ref-vol">11</span>:791–801.</span> [<a href="/pubmed/17141155" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17141155</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.tanaka.1990.179">Tanaka H, Yasui N, Kuriskaki E, Shimomura Y. The Goltz syndrome associated with giant cell tumour of bone. A case report. <span><span class="ref-journal">Int Orthop. </span>1990;<span class="ref-vol">14</span>:179–81.</span> [<a href="/pubmed/2373565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2373565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.tanaka.2000.4300">Tanaka K, Okabayashi K, Asashima M, Perrimon N, Kadowaki T. The evolutionarily conserved porcupine gene family is involved in the processing of the Wnt family. <span><span class="ref-journal">Eur J Biochem. </span>2000;<span class="ref-vol">267</span>:4300–11.</span> [<a href="/pubmed/10866835" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10866835</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.tejani.2005.67">Tejani Z, Batra P, Mason C, Atherton D. Focal dermal hypoplasia: oral and dental findings. <span><span class="ref-journal">J Clin Pediatr Dent. </span>2005;<span class="ref-vol">30</span>:67–72.</span> [<a href="/pubmed/16302603" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16302603</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.tenkir.2010.28">Tenkir A, Teshome S. Goltz syndrome (focal dermal hypoplasia) with unilateral ocular, cutaneous and skeletal features: case report. <span><span class="ref-journal">BMC Ophthalmol. </span>2010;<span class="ref-vol">10</span>:28.</span> [<a href="/pmc/articles/PMC2996349/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2996349</span></a>] [<a href="/pubmed/21092077" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21092077</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.van_allen.1991.523">Van Allen MI, Myhre S. New multiple congenital anomalies syndrome in a stillborn infant of consanguinous parents and a prediabetic pregnancy. <span><span class="ref-journal">Am J Med Genet. </span>1991;<span class="ref-vol">38</span>:523–8.</span> [<a href="/pubmed/2063890" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2063890</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.van_amerongen.2009.3205">van Amerongen R, Nusse R. Towards an integrated view of Wnt signaling in development. <span><span class="ref-journal">Development. </span>2009;<span class="ref-vol">136</span>:3205–14.</span> [<a href="/pubmed/19736321" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19736321</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.vreeburg.2011.592">Vreeburg M, van Geel M, van den Heuij LG, Steijlen PM, van Steensel MA. Focal dermal hypoplasia in a male patient due to mosaicism for a novel PORCN single nucleotide deletion. <span><span class="ref-journal">J Eur Acad Dermatol Venereol. </span>2011;<span class="ref-vol">25</span>:592–5.</span> [<a href="/pubmed/20626533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20626533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.wang.2007.836">Wang X, Sutton VR, Peraza-Llanes OJ, Yu Z, Rosetta R, Kou YC, Eble TN, Patel A, Thaller C, Fang P, Van den Veyver IB. Pathogenic variants in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:836–8.</span> [<a href="/pubmed/17546030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17546030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.wechsler.1988.297">Wechsler MA, Papa CM, Haberman F, Marion RW. Variable expression in focal dermal hypoplasia. An example of differential X-chromosome inactivation. <span><span class="ref-journal">Am J Dis Child. </span>1988;<span class="ref-vol">142</span>:297–300.</span> [<a href="/pubmed/3344717" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3344717</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.wimplinger.2006.878">Wimplinger I, Morleo M, Rosenberger G, Iaconis D, Orth U, Meinecke P, Lerer I, Ballabio A, Gal A, Franco B, Kutsche K. Pathogenic variants of the mitochondrial holocytochrome c-type synthase in X-linked dominant microphthalmia with linear skin defects syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">79</span>:878–89.</span> [<a href="/pmc/articles/PMC1698567/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1698567</span></a>] [<a href="/pubmed/17033964" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17033964</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.wright.2016.52">Wright JT, Puranik CP, Farrington F. Oral phenotype and variation in focal dermal hypoplasia. <span><span class="ref-journal">Am J Med Genet C Semin Med Genet. </span>2016;<span class="ref-vol">172C</span>:52–8.</span> [<a href="/pubmed/26843121" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26843121</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="focal-dh.REF.yoshihashi.2011.550">Yoshihashi H, Ohki H, Torii C, Ishiko A, Kosaki K. Survival of a male mosaic for PORCN pathogenic variant with mild focal dermal hypoplasia phenotype. <span><span class="ref-journal">Pediatr Dermatol. </span>2011;<span class="ref-vol">28</span>:550–4.</span> [<a href="/pubmed/21133992" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21133992</span></a>]</div></li></ul></div></div><div id="focal-dh.Chapter_Notes"><h2 id="_focal-dh_Chapter_Notes_">Chapter Notes</h2><div id="focal-dh.Author_Notes"><h3>Author Notes</h3><p><a href="https://www.bcm.edu/people/view/vernon-sutton-m-d/b2793582-ffed-11e2-be68-080027880ca6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dr. Sutton's website</a></p><p><a href="https://www.bcm.edu/people/view/b1869171-ffed-11e2-be68-080027880ca6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dr. Van den Veyver's website</a></p></div><div id="focal-dh.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 July 2016 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 April 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 May 2008 (me) Review posted live</div></li><li class="half_rhythm"><div>6 February 2008 (vrs) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1543</span><span class="label">PMID: <a href="/pubmed/20301712" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301712</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/fhs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/issd/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1543&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1543/?report=reader">PubReader</a></li><li><a href="/books/NBK1543/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1543" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1543" style="display:none" title="Cite this Page"><div class="bk_tt">Bostwick B, Van den Veyver IB, Sutton VR. Focal Dermal Hypoplasia. 2008 May 15 [Updated 2016 Jul 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1543/pdf/Bookshelf_NBK1543.pdf">PDF version of this page</a> (2.9M)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#focal-dh.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#focal-dh.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#focal-dh.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#focal-dh.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#focal-dh.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#focal-dh.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#focal-dh.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#focal-dh.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#focal-dh.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#focal-dh.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#focal-dh.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=64840[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PORCN</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1460308" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1460308" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1460308" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1460308" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21634086" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Chondrodysplasia Punctata 2, X-Linked</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Chondrodysplasia Punctata 2, X-Linked<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dempsey MA, Tan C, Herman GE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25040319" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Goltz syndrome and PORCN mosaicism.</a><span class="source">[Int J Dermatol. 2014]</span><div class="brieflinkpop offscreen_noflow">Goltz syndrome and PORCN mosaicism.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Stevenson DA, Chirpich M, Contreras Y, Hanson H, Dent K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int J Dermatol. 2014 Dec; 53(12):1481-4. Epub 2014 Jul 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301767" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Microphthalmia with Linear Skin Defects Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Microphthalmia with Linear Skin Defects Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Morleo M, Franco B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301567" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Robertson S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301645" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Incontinentia Pigmenti</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Incontinentia Pigmenti<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Scheuerle AE, Ursini MV. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301712" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301712" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0415a575f66d18aa4f1dfc">Focal Dermal Hypoplasia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Focal Dermal Hypoplasia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:06:29-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C476BE0409F510000000004E901D4&amp;ncbi_session=CE8C476BE0415A51_1257SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1543%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1543&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1543/&amp;ncbi_pagename=Focal Dermal Hypoplasia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C476BE0415A51_1257SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>